3D genome organisation is disrupted across multiple brain cell types in Alzheimer's disease

A study reported by ScienceDaily describes researchers identifying widespread disruption to the three-dimensional organisation of chromatin — the higher-order structure in which DNA is packaged inside the cell nucleus — across multiple brain cell types implicated in Alzheimer's disease. Rather than examining which genes are mutated or simply which genes are active, the work focuses on how the physical folding and looping of the genome affects the regulation of gene expression in affected cells.

This layer of regulation, sometimes called three-dimensional genomics or chromatin architecture, governs which enhancer sequences can physically contact which gene promoters, thereby controlling when and how strongly individual genes are expressed. The researchers found that these spatial contacts are disrupted in Alzheimer's-affected brain cells in ways that alter the activity of genes relevant to the disease — adding a regulatory dimension that sits largely upstream of, or in parallel to, changes in DNA sequence.

The original announcement does not name the lead institution, researchers, or the journal in which the findings were published. The ScienceDaily report does not provide sufficient detail to identify the primary source. Readers seeking full methodological detail are encouraged to identify the peer-reviewed publication directly.

The work contributes to a growing body of research examining how epigenomic and chromatin-structural changes — rather than coding mutations alone — contribute to late-onset neurodegenerative disease. Earlier clusters on this feed have examined related questions through the lens of APOE mRNA editing and APOE isoform biology; the present findings add a chromatin-architecture perspective to that picture.